Warner-Lambert Pharmaceutical Company

Wilbert, G. and De Angel is, J. U.S. Patent 2,998,450 August 29,1961 assigned to Warner-Lambert Pharmaceutical Company. [Pg.15]

G.B. Patent No. 1,123,457 11 August 11, 1966 Warner Lambert Pharmaceutical Company, a Corporation of Delaware, USA... [Pg.396]

Kaminsky, D. and Meltzer, R.I. US Patent 3,287,458 November 22, 1966 assigned to Warner-Lambert Pharmaceutical Company... [Pg.2566]

Wendell A. Peterson Parke-Davis Pharmaceutical Research Division of Warner-Lambert Company, Ann Arbor, Michigan, U.S.A. [Pg.9]

MICHAEL LEVIN is President and CEO, Metropolitan Computing Corporation (MCC), East Hanover, New Jersey, specializing in process analytical instrumentation as well as data acquisition and control systems for tablet presses, mixers, roller compactors, and other equipment. Prior to forming MCC in 1985, he was a consultant to pharmaceutical companies such as Merck, Sandoz, and Warner-Lambert. A member of the American Association of Pharmaceutical Scientists, the International Society for Pharmaceutical Engineering, and the Biomedical Engineering Society, Dr. Levin received the Ph.D. degree (1985) in biomathematics from the University of Washington, Seattle. [Pg.539]

P. Goel, U. Krolls, M. Stler, and S. Kesten, Warner-Lambert Company, Pharmaceutical Research Division, 2800 Plymouth Road, Ann Arbor, MI 48105... [Pg.128]

Within the pharmaceutical industry itself, the wish of each company s management to see its firm reach what is considered a critical size remained a constant feature as the century came to an end and the new millennium began. It led to new national and transnational mergers. In France, Sanofi (Elf Aquitaine) merged with Synthelabo (L Oreal) and Laboratoires Pierre Fabre with BioMerieux. Elsewhere the Swedish Astra and the British Zeneca combined their operations Pharmacia-Upjohn took control of Monsanto and two giant firms, Glaxo Wellcome and SmithKline Beecham, announced their intention to combine their activities, which would lead to a group with a turnover of 25 billion, exceeded only by Pfizer after its acquisition of Warner Lambert. [Pg.45]

Takeda Pharmaceutical Company Limited Vertex Pharmaceuticals Incorporated Warner Lambert Company Wyeth... [Pg.671]

There has been and will continue to be iimovative reconstruction of the pharmaceutical industry with, for example, cross-licensing of products and expertise. Sandoz collaborated with Bristol Myers Squibb (BMS) in oncology. Other companies have a more acquisitive outlook. Pfizer bought Warner-Lambert for its cholesterol-lowering Lipitor, and Pharmacia merged with UpJohn-Searle for its COX-2 inhibitor. Pfizer then acquired Pharmacia-UpJohn-Searle to become the world s largest pharmaceutical company. [Pg.10]

Brock A. Luty, Tami Marrone, and Peter W. Rose Agouron Pharmaceuticals, Inc., A Warner-Lambert Company 10777 Science Center Drive, San Diego, CA 92121-1111 USA... [Pg.289]

Warner-Lambert Company, Parke-Davis Pharmaceutical Research, 2800 Plymouth Road, Ann Arbor, MI 48105. [Pg.74]

Parke-Davis Pharmaceutical Research Division Warner-Lambert Company... [Pg.437]

Horwell, D. C., Bryans, J. S., Kneen, C. O., Morrell, A. 1., RatcUffe, G. S. Preparation of novel bridge cyclic amino acids as pharmaceutical agents W09733859 (Warner-Lambert Company (USA)), 1997. [Pg.361]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...